​BIBLIOGRAFÍA CÁNCER DE MAMA

​

1. Martín M, Llombart-Cussac A, Lluch A, et al. Estudio epidemiológico del grupo GEICAM sobre el cáncer de mama en España (1990-1993): proyecto “El Álamo”. Med Clin 2004; 122(1):12-17.

2. Algara M, Valls A, Foro P et al. Control local y resultado estético en el tratamiento conservador del cáncer de mama. Análisis de 397 casos consecutivos. Rev Clin Esp 1999; 199(1): 18-24.

3. Algara M, Sanz X, Foro P et al. Use of radiation treatment units in breast cancer. Changes in last 15 years. Clin Transl Oncol 2008; 10:47-51.

4. Early Breast Cancer Trialists' Collaborative Group (EbCTCG), Darby S, McGale P, et al. Effect of Radiotherapy after Breast -Conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for

5. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER et al. Twenty-year follow-up of a randomized trialcomparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N.Engl.J.Med.2002;347: 1233-41.

6. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al. Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer. New Engl. J. Med. 2002;347: 1227-32.

7. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann.Oncol. 2001;12: 997-1003.

8. Christiansen P, Carstensen SL, Ejlertsen B,  et al. Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol. 2018 Jan; 57(1):19-25.

9. Corradini S, Reitz D, Pazos M, et al. Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases. Cancers (Basel). 2019 Jan 31;11(2). pii: E160. doi: 10.3390/cancers11020160.

10. McCormick B, Ottesen RA, Hughes ME, et al.  Impact of guideline changes on use or omission of radiation in the elderly with early breastcancer: practice patterns at National Comprehensive Cancer Network institutions. J Am Coll Surg. 2014 Oct;219(4): 796-802.

11. Algara M, Sanz X, Foro P et al. N Risk factors of local relapse in breast cancer: the importante of age. Clin Transl Oncol 2007; 9: 110-6.

12. Polgár C, Fodor J, Major T, Sulyok Z, Kásler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013 Aug;108(2): 197-202.

13. Polgár C, Van Limbergen E, Pötter R. Patient selection for accelerated partial-breast irradiation (apbi) after breast-conserving surgery: recommendations of the groupe européen de curiethérapie-european society for therapeutic radiology and oncology (GEC-ESTRO) Breast Cancer Working Group based on clinical evidence. Radiother Oncol 2010; 94(3): 264-73.

14. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009; 74: 987-1001.

15. Candace C. Eleanor E. Maria C. Benjamin D. Smith, Alphonse G. Taghian, Alastair M. Thompson, Julia W. Jay R. Harris. Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence- Based Consensus Statement. Practical Radiation Oncology (2016)

16. Rodríguez N, Sanz X, Dengra J, Foro P, Membrive I, Reig A, Quera J, Fernández-Velilla E, Pera O, Lio J, Lozano J, Algara M. Five-Year Outcomes, Cosmesis, and Toxicity With 3-Dimensional Conformal External Beam Radiation Therapy to Deliver Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2013; 87(5): 1051-7.

17. Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 2013; 14: 1269.

18. Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted tageted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from TARGIT-A randomised trial. Lancet 2014; 383: 603.

19. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of breast Radiotherapy (START) trials of radiotherapy hipofractionation for treatment of early breast cancer: 10-yera follow-up results of two randomised controlled trials. Lancet Oncol 2013; 14: 1086

20. Whelan TJ1, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010 Feb 11;362(6): 513-20.

21. The Start Trialists Group. The UK Standarisation of breast Radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008; 371(9618): 1098-107.

22. Munshi A, Budrukkar A. Hypofractionated radiation therapy in breast cancer: a revolutionary breakthrough or a long way to go?. J Clin Oncol 2007; 25(4): 458-9.

23. Smith BD, Bentzen SM, Correa CR, et al. Fraction for whole breast irradiation: an american Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 81: 89.

24. Montero A, Sanz X, Hernanz R, Cabrera D, Arenas M, Bayo E, Moreno F, Algara M. Accelerated hypofractionated breast radiotherapy: FAQs

25. Yarnold J, Bentzen S, Coles C, Haviland J. Hypofractionated whole-brast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011; 79: 1-9.

26. Algara M, Arenas M, De las Peñas D, et al. Breast Cancer Radiation Oncology Spanish Group (GEORM). Radiation techniques used in patients with breast cancer: results of a survey in Spain. Rep Pract Oncol Radiother  2012; 17(3): 122-8.

27. Prades J, Algara M, Espinàs JA, Farrús B, Arenas M, Reyes V, García-Reglero V, Cambra MJ, Rubio E, Anglada L, Eraso A, Pedro A, Fuentes-Raspall MJ, Tuset V, Solà J, Borras JM. Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study. Radiother Oncol. 2017 Apr;123(1): 22-28.

28. Sanz J, Rodríguez N, Foro P, Dengra J, Reig A, Pérez P, Membrive I, Ortiz A, Codinach M, Algara M. Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis. Clin Transl Oncol. 2017 Apr;19(4): 464-469.

29. Montero A, Algara M. Manejo de la axila en el cáncer de mama: menos es más, más es menos o todo lo contrario. Revista de Senología y Patología Mamaria. 2016; 29(1): 1-3.

30. Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018 Oct;19(10): 1385-1393. [1] EBCTCG (Early Breast Cancer Trialists' Collaborative Group). Effect of radiotherapy after mastectomy and axillary surgery on 10-yearrecurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014 Jun 21;383(9935): 2127-35.

31. Whelan TJ, Olivotto IA, Parulekar WR et al MA.20 Study Investigators.Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015 Jul 23;373(4): 307-16.

32. Poortmans PM, Collette S, Kirkove C, et al. EORTC Radiation Oncology and Breast Cancer Groups. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med. 2015 Jul 23;373(4): 317-27.

33. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. A randomized clinical trial. JAMA 2011; 305(6): 569-575.

34. Haffty BG, Hunt KK, Harris JR, Buchholz TA. Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol. 2011 Dec 1;29(34): 4479–81.

35. Bayo E, Herruzo I, Arenas M, Algara M. Consensus on the regional lymph nodes irradiation in breast cancer. Clin Transl Oncol 2013; 15(10): 766-73. [1] Donker M, van Tienhoven G, Straver ME  et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014 Nov;15(12): 1303-10.

36. Sávolt Á, Péley G, Polgár C, et al. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017 Apr;43(4): 672-679.

37. Gebhardt BJ, Thomas J, Horne ZD, et al. Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network. Pract Radiat Oncol. 2018 Jan - Feb;8(1): 4-12.

38. Goyal S, Haffty BG. Targeting regional nodal basins in breast cancer patients: exactly what are we treating? Ann Surg Oncol. 2014 Nov;21(12):3715-6. [1] Aristei C, Kaidar-Person O, Arenas M, et al. The 2016 Assisi Think Thank Meeting on breast cancer: white paper. Breast Cancer Res Treat 2016; 160(2): 211-221.

39. Recht A, Comen EA, Fine RE et al Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology and  Oncology, and Society of Surgical Oncology Focused Guideline Update. J Clin Oncol. 2016 Dec 20;34(36): 4431-4442. [1] Harris JR. Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes. JAMA Oncol. 2016 Aug 1;2(8): 991-2.

40. Jagsi R, Chadha M, Moni J, Ballman K, Laurie F, Buchholz TA, Giuliano A, Haffty BG. Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol 2014; 32(32): 3600-6.

41. Poortmans PM, Coles C, Bernier J. Treatment of Regional Lymph Nodes in Breast Cancer-Evidence in Favor of Radiation Therapy. JAMA Oncol. 2016 Aug 1;2(8): 989-90. [1] Thorsen LB, Offersen BV, Danø H et al. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2016 Feb 1;34(4): 314-20.

42. Wang SL, Fang H, Song YW,et al. Hypo fractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019 Jan 30. pii: S1470-2045(18)30813-1. doi: 10.1016/S1470-2045(18)30813-1. [Epub ahead of print]

43. Arenas M, Montero Á, de Las Peñas MD, Algara M. The position and current status of radiation therapy after primary systemic therapy in breast cancer: a national survey-based expert consensus statement. Clin Transl Oncol. 2016 Jun;18(6): 582-91.

44. Kantor O, Pesce C, Singh P, et al. Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy. J Surg Oncol. 2017 May;115(6): 668-676.

45. Krug D, Baumann R, Budach W, et al. Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review. Strahlenther Onkol. 2018 Jul;194(7): 607-618.

46. Algara M, Piñero A., Salinas J., Gómez G. Radioterapia y técnicas de reconstrucción mamaria Rev Senologia Patol Mam 2013; 26(1): 25-32.

47. Ho AY1, Hu ZI2, Mehrara BJ3, Wilkins EG4. Radiotherapy in the setting of breast reconstruction: types, techniques, and timing. Lancet Oncol. 2017 Dec;18(12): e742-e753.

48. Rosson GD, Magarakis M, Shridharani SM, et al. A review of the surgical management of breast cancer: plastic reconstructive techniques and timing implications. Ann Surg Oncol. 2010 Jul;17(7): 1890-900.

49. Khan AJ, Poppe MM, Goyal S, et al. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. J Clin Oncol. 2017 Jun 20;35(18): 2037-2043.

50. Whitfield GA, Horan G, Irwin MS, Malata CM, Wishart GC, Wilson CB. Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gray in 15 fractions. Radiother Oncol. 2009 Jan;90(1): 141-7.

51. Poortmans P., Marsiglia H., De las Heras M., Algara M., Clínical and technological transition in breast cancer. Rep Pract Oncol Radiother 2013: 6(18): 345-352.